Drug Approval | April 17, 2026
Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The new unit is expected to serve thousands of patients annually, helping address a critical gap in dialysis access
The new outpatient-focused clinic is designed to address voice, airway and swallowing disorders through advanced diagnostics
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
Collaboration aims to align hospital staff learning with NABH 6th Edition standards, patient safety, and measurable quality outcomes
The goal is to better support drug developers as programs move from laboratory research into clinical trials
To boost compostable packaging, resin innovation, and supply chain speed
Subscribe To Our Newsletter & Stay Updated
